Variable efficacy of the non-covalent KRAS<sup>G12D</sup> inhibitor (MRTX-1133) with obesity in murine pancreatic cancer.
Authors
- Lyse A. Norian (ORCID: https://orcid.org/0000-0003-1016-313X)
- Henry Nnaemeka Ogbonna (ORCID: https://orcid.org/0000-0003-2740-1683)
- Jianqing Zhang (ORCID: https://orcid.org/0000-0001-5246-3371)
- Pia Muri
- Dhana Sekar Reddy Bandi
- Karen Aikhionbare
- Cherlene Hardy
- J B Foote
- Sujith Sarvesh
- Ganji Purnachandra Nagaraju
- Bassel F El-Rayes
- Holly Stephens
Institutions
- University of Kentucky (US)
- University of Alabama at Birmingham (US)
- University of California San Diego Medical Center (US)